| |
HIV (N = 2,548)
|
TB (N = 197,562)
|
HIV & TB (N = 137)
|
|---|
|
Sex, male : female
|
2,355(92.4%):193(7.6%)
|
124,183(62.9%):73,379(37.1%)
|
132(96.4%):5(3.6%)
|
|
Age, median (range)
|
37.0 (4-80)
|
44 (0-97)
|
39.5 (19.9-79.1)
|
|
0-9
|
2 (0.1%)
|
1,000 (0.5%)
|
0 (0%)
|
|
10-19
|
60 (2.4%)
|
12,575 (6.4%)
|
1 (0.7%)
|
|
20-29
|
576 (22.6%)
|
39.638 (20.1%)
|
19 (13.9%)
|
|
30-39
|
873 (34.3%)
|
32,231 (16.3%)
|
51 (37.2%)
|
|
40-49
|
583 (22.9%)
|
30,515 (15.4%)
|
41 (29.9%)
|
|
50-59
|
318 (12.5%)
|
23,206 (11.7%)
|
14 (10.2%)
|
|
60-
|
136 (5.3%)
|
58,397 (29.6%)
|
11 (8.0%)
|
|
Year
|
Cases
|
Incidence (cases/105)
|
Cases
|
Incidence (cases/105)
|
Cases
|
Incidence (cases/105)
|
|
2001
|
327
|
0.69
|
42,737
|
90.3
|
17
|
0.036
|
|
2002
|
398
|
0.84
|
38,801
|
81.4
|
20
|
0.042
|
|
2003
|
534
|
1.11
|
36,227
|
75.6
|
21
|
0.044
|
|
2004
|
610
|
1.27
|
36,041
|
74.8
|
40
|
0.083
|
|
2005
|
680
|
1.41
|
43,781
|
90.7
|
39
|
0.081
|
|
CD4 count at diagnosis, median(IQR) (/mm3)
|
315.0 (186.0-464.0)
| | |
301.0 (171.5-460.0)
|
|
TB type (% among patients with TB)
| | | | | | |
|
Pulmonary
| | |
183,640 (92.0%)
| |
111 (81.0%)
| |
|
Smear positive
| | |
72,599 (36.4%)
| |
42 (30.7%)
| |
|
Extrapulmonary
| | |
16,021 (8.0%)
| |
26 (19.0%)
| |
|
Pleurisy
| | |
6,852 (3.4%)
| |
3 (2.2%)
| |
|
Lymphnode
| | |
3,675 (1.8%)
| |
10 (7.3%)
| |
|
Gastrointestinal
| | |
1,797 (0.9%)
| |
5 (3.6%)
| |
|
Nervous
| | |
657 (0.3%)
| |
3 (2.2%)
| |
|
Skin
| | |
272 (0.1%)
| |
1 (0.7%)
| |
|
Other organs
| | |
2,169 (1.1%)
| |
1 (0.7%)
| |
|
Disseminated
| | |
599 (0.3%)
| |
3 (2.2%)
| |
